首页> 外国专利> CO-CRYSTALLIZATION OF TRANSACTIVATION DOMAIN E2 OF THE HUMAN / INHIBITOR PAPILOMA VIRUS AND X-RAY COORDINATES DEFINING THE INHIBITOR UNION POCKET.

CO-CRYSTALLIZATION OF TRANSACTIVATION DOMAIN E2 OF THE HUMAN / INHIBITOR PAPILOMA VIRUS AND X-RAY COORDINATES DEFINING THE INHIBITOR UNION POCKET.

机译:人/抑制剂脂蛋白病毒的交易域E2和X射线坐标共结晶,定义了抑制剂联盟小袋。

摘要

The use of the atomic coordinates of H32, W33 and L94 as defined in Figure 9 to identify a potential inhibitor of a molecule comprising a TAD type E2 binding pocket of HPV comprising the steps of: a) the use of the atomic coordinates of H32, W33 and L94 as defined in Figure 9 to generate a three-dimensional structure of the molecule comprising a TAD type E2 binding pocket; b) using said 3-D structure to design or select said potential inhibitor; c) synthesizing said inhibitor; d) contacting said inhibitor with said molecule to determine the ability of said potential inhibitor to interact with said molecule.
机译:使用图9中定义的H32,W33和L94的原子坐标来鉴定包含HPV的TAD E2型结合口袋的分子的潜在抑制剂,包括以下步骤:a)使用H32的原子坐标,如图9所定义的W33和L94产生包含TAD E2型结合口袋的分子的三维结构; b)使用所述3-D结构设计或选择所述潜在抑制剂; c)合成所述抑制剂; d)使所述抑制剂与所述分子接触以确定所述潜在抑制剂与所述分子相互作用的能力。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号